Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.850
-0.060 (-3.14%)
At close: Jan 23, 2026, 4:00 PM EST
1.836
-0.014 (-0.78%)
After-hours: Jan 23, 2026, 5:42 PM EST
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $76.31 million as of January 23, 2026. Its market cap has decreased by -70.77% in one year.
Market Cap
76.31M
Enterprise Value
56.32M
1-Year Change
-70.77%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $76.31M, a decrease of -94.28%. That is a compound annual growth rate of -41.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 76.31M | -16.29% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Picard Medical | 128.98M |
| Sera Prognostics | 124.85M |
| MaxCyte | 123.74M |
| Hyperfine | 120.49M |
| Outset Medical | 92.76M |
| Accuray | 92.46M |
| Xtant Medical Holdings | 91.39M |
| Sensus Healthcare | 79.33M |